Figure 1From: A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors Blood concentration profiles (arithmetic mean +/− SD) of ridaforolimus following administration of a single oral dose or multiple once daily dosages of 40 mg of ridaforolimus in Chinese patients with advances or metastatic solid tumors (Day 1 n = 15 and Day 19 n = 13). Back to article page